Cherine Bechara

Cherine Bechara

Auto-generated profile, based on publicly available information

Cherine Bechara

Institut de Génomique Fonctionnelle, University of Montpellier, CNRS, INSERM, 34094 Montpellier Cedex 5, France

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 May 2013 in FEBS Letters
Verified
Journal Article
Open access
CBChérine Bechara
Chérine Bechara
SSSandrine SAGAN
Sandrine SAGAN
Twenty years ago, the discovery of peptides able to cross cellular membranes launched a novel field in molecular delivery based on these non‐invasive vectors, most commonly called cell‐penetrating peptides (CPPs) or protein transduction domains (PTDs). These peptides were shown to efficiently transport various biologically active molecules inside living cells, and thus are considered promising devices for medical and biotechnological developments. Moreover, CPPs emerged as potential tools to study the prime mechanisms of cellular entry across the plasma membrane. This review is dedicated to CPP fundamentals, with an emphasis on the molecular requirements and mechanism of their entry into eukaryotic cells.

22 February 2016 in Nature Methods
Verified
Journal Article
Open access
PDF file
JGJoseph Gault
Joseph Gault
JDJoseph A C Donlan
Joseph A C Donlan
ILIdlir Liko
Idlir Liko
JHJonathan T S Hopper
Jonathan T S Hopper
KGKallol Gupta
Kallol Gupta
CRCarol V Robinson
Carol V Robinson
A high-resolution, Orbitrap-based, native mass spectrometry approach allows the direct characterization of lipid, peptide and drug binding to intact membrane proteins. Small molecules are known to stabilize membrane proteins and to modulate their function and oligomeric state, but such interactions are often hard to precisely define. Here we develop and apply a high-resolution, Orbitrap mass spectrometry–based method for analyzing intact membrane protein–ligand complexes. Using this platform, we resolve the complexity of multiple binding events, quantify small molecule binding and reveal selectivity for endogenous lipids that differ only in acyl chain length.

22 March 2017 in Nature
Verified
Journal Article
Closed access
PDF file
IVIeva Vasiliauskaité-Brooks
Ieva Vasiliauskaité-Brooks
RSRemy Sounier
Remy Sounier
PRPascal Rochaix
Pascal Rochaix
GBGaëtan Bellot
Gaëtan Bellot
MFMathieu Fortier
Mathieu Fortier
SGSébastien Granier
Sébastien Granier

2 February 2015 in Nature Chemistry
Verified
Journal Article
Closed access
PDF file
CBChérine Bechara
Chérine Bechara
ANAnne Nöll
Anne Nöll
NMNina Morgner
Nina Morgner
MDMatteo Degiacomi
Matteo Degiacomi
RTRobert Tampé
Robert Tampé
CRCarol V. Robinson
Carol V. Robinson

16 November 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
JGJakub Gruszczyk
Jakub Gruszczyk
LGLoïc Grandvuillemin
Loïc Grandvuillemin
JLJosephine Lai-Kee-Him
Josephine Lai-Kee-Him
MPMatteo Paloni
Matteo Paloni
CSChristos G. Savva
Christos G. Savva
WBWilliam Bourguet
William Bourguet
The aryl hydrocarbon receptor (AHR) is a ligand-dependent transcription factor that mediates a broad spectrum of (patho)physiological processes in response to numerous substances including pollutants, natural products and metabolites. However, the scarcity of structural data precludes understanding of how AHR is activated by such diverse compounds. Our 2.85 Å structure of the human indirubin-bound AHR complex with the chaperone Hsp90 and the co-chaperone XAP2, reported herein, reveals a closed conformation Hsp90 dimer with AHR threaded through its lumen and XAP2 serving as a brace. Importantly, we disclose the long-awaited structure of the AHR PAS-B domain revealing a unique organisation of the ligand-binding pocket and the structural determinants of ligand-binding specificity and promiscuity of the receptor. By providing structural details of the molecular initiating event leading to AHR activation, our study rationalises almost forty years of biochemical data and provides a framework for future mechanistic studies and structure-guided drug design.

15 October 2012 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
CBChérine Bechara
Chérine Bechara
MPManjula Pallerla
Manjula Pallerla
YZYefim Zaltsman
Yefim Zaltsman
FBFabienne Burlina
Fabienne Burlina
Isabel AlvesIsabel Alves
Isabel Alves
SSSandrine SAGAN
Sandrine SAGAN
Deciphering the structural requirements and mechanisms for internalization of cell‐penetrating peptides (CPPs) is required to improve their delivery efficiency. Herein, a unique role of tryptophan (Trp) residues in the interaction and structuring of cationic CPP sequences with glycosaminoglycans (GAGs) has been characterized, in relation with cell internalization. Using isothermal titration calorimetry, circular dichroism, NMR, mass spectrometry, and phase‐contrast microscopy, we compared the interaction of 7 basic CPPs with 5 classes of GAGs. We found that the affinity of CPPs for GAGs increases linearly with the number of Trp residues, from 30 nM for a penetratin analog with 1 Trp residue to 1.5 nM for a penetratin analog with 6 Trp residues for heparin (HI); peptides with Trp residues adopt a predominantly β‐strand structure in complex with HI and form large, stable β‐sheet aggregates with GAGs; and in the absence of any cytotoxicity effect, the quantity of peptide internalized into CHO cells increased 2 times with 1 Trp residue, 10 times with 2 Trp residues, and 20 times with 3 Trp residues, compared with +6 peptides with no Trp residues. Therefore, Trp residues represent molecular determinants in basic peptide sequences not only for direct membrane translocation but also for efficient endocytosis through GAGs.—Bechara, C., Pallerla, M., Zaltsman, Y., Burlina, F., Alves, I. D., Lequin, O., Sagan S. Tryptophan within basic peptide sequences triggers glycosaminoglycan‐dependent endocytosis. FASEB J. 27, 738–749 (2013). www.fasebj.org